City of Hope

www.cityofhope.org

 

City of Hope
E

Prevalence of EGFR Mutation Testing in Early Stage Lung Cancer: Implications of the ADAURA Trial for Clinical Practice

By City of Hope FEATURING Erminia Massarelli
By City of Hope FEATURING Erminia Massarelli
173 views
October 7, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Lung
22:21
Total Health

Immunotherapy for SCLC - Best of Lung 2023

Feat. J. Malhotra
14:29
Total Health

Updates on Universal Comprehensive Genomic Profiling & Treatment…

Feat. R. Salgia
17:44
Total Health

Novel Approaches in the Treatment of NSCLC

Feat. E. Massarelli
05:10
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "LUNAR Trial Key Learnings & Clinical …

Feat. J. West
07:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…

Feat. J. West
16:21
City of Hope

Prevalence of EGFR Mutation Testing in Early Stage Lung Cancer: Impl…

Feat. E. Massarelli
14:09
City of Hope

ASCO 2021 Highlights From IMpower 010 on Resected Stage IB-IIIA NSCL…

Feat. J. West
13:56
City of Hope

Atezolizumab in ES-SCLC: Efficacy Data Overview of Atezo+Chemo Durin…

Feat. V. Villaflor
06:27
Virtual West Oncology Conference

Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approv…

Feat. E. Massarelli
05:28
Virtual West Oncology Conference

2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety …

Feat. E. Massarelli
06:49
Virtual West Oncology Conference

Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Efficac…

Feat. E. Massarelli
11:47
City of Hope

The Use of Biomarkers in Lung Cancer Treatment

Feat. K. Reckamp